Surveillance as an Option for the Treatment of Small Renal Masses

by S. Klaver, S. Joniau, H. Van Poppel
Published 2008-01-01

The use of immunotherapy for metastatic renal cell carcinoma

by L. Goeman, S. Joniau, H. Van Poppel
Published 2020-02-01

Preclinical Evidence for the Benefits of Penile Rehabilitation Therapy following Nerve-Sparing Radical Prostatectomy

by M. Albersen, S. Joniau, H. Claes, H. Van Poppel
Published 2008-01-01

Clinical relevance of prostate cancer genetic characterization: literature review

by Yu. Tolkach, S. Reva, A. Nosov, F. Imkamp, H. Van Poppel
Published 2015-06-01

The role of cytoreductive nephrectomy in the contemporary management of metastatic kidney cancer: Predictive factors for surgical complications and oncological survival

by E. Roussel, A. Verbiest, U. Milenkovic, W. Everaerts, B. Van Cleynenbreugel, H. Van Poppel, S. Joniau, B. Beuselinck, G. Devos, T. Muilwijk, M. Albersen
Published 2020-07-01

Analysis of results of bicalutamide monotherapy versus castration in patients with non-metastatic locally advanced prostate cancer during 6.3-year follow-up

by P. Iversen, C. J. Tyrrel, A. V. Kaisary, J. B. Anderson, H. van Poppel, T. L.J. Tammela, M. Chamberlain, K. Carrol, I. Melezinek
Published 2020-02-01

Patient and region based accuracy of PSMA PET/CT in patients undergoing salvage lymphadenectomy for lymph node recurrence following primary treatment

by G. Devos, A. Vanderstichele, H. Van Eecke, C. Berghen, T. Muilwijk, E. Roussel, A. Clinckaert, M. Albersen, H. Van Poppel, W. Everaerts, G. De Meerleer, S. Joniau
Published 2020-07-01

The Cancer Of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: External validation in a large bi-institutional European c...

by T. Muilwijk, M. Akand, F. Soria, A. Giordano, U. Milenkovic, L. Moris, L. Demaegd, G. Devos, E. Roussel, T. Gevaert, H. Van Poppel, M. Albersen, P. Gontero, S. Joniau
Published 2020-07-01

Genomic analysis of localized prostate cancer identifies AZIN1 as driver of metastatic progression

by L. Moris, T. Van Den Broeck, T. Gevaert, E. Smeets, C. Helsen, F. Handle, H. Van Poppel, W. Everaerts, D. Lambrechts, C. Buerki, E. Davicioni, S. Joniau, F. Claessens
Published 2020-07-01

Long-term outcomes of clinically node-positive prostate cancer patients treated with radical prostatectomy as part of a multimodal treatment: patterns of recurrence and impact on c...

by D. Cannoletta, G. Gandaglia, R. Karnes, G. Devos, C. Berghen, W. Everaerts, G. Motterle, S. Joniau, A. Clinckaert, D. Robesti, F. Scalvi, N. Fossati, H. Van Poppel, V. Cucchiara, A. Rizzo, E. Zito, F. Dehò, M. Droghetti, A. Pellegrino, P.I. Karakiewicz, A. Stabile, A. Martini, F. Montorsi, A. Briganti
Published 2020-10-01

Association between the extent of lymph node dissection and severe toxicity in men with prostate cancer treated with post-prostatectomy radiation therapy: results from a large mult...

by N. Fossati, R.J. Karnes, S. Boorjian, G. Motterle, A. Bossi, E. Mazzone, V. Cucchiara, S. Scuderi, E. Zito, G. Gandaglia, T. Kumar, N. Di Muzio, C. Cozzarini, B.Noris Chiorda, D. Bartkowiak, S. Shariat, G. Goldner, G. Devos, S. Joniau, C. Berghen, G. De Meerleer, H. Van Poppel, F. Montorsi, T. Wiegel, A. Briganti
Published 2020-10-01

Risk of death from prostate cancer in patients with biopsy Gleason score 6 and additional clinical high-risk features: A European multi-institutional study

by D. Milonas, T. Muilwijk, Z. Venclovas, G. Devos, A. Briganti, P. Gontero, J. Karnes, P. Chlosta, F. Chun, W. Everaerts, C. Gratzke, M. Albersen, M. Graefen, B. Kneitz, G. Marchioro, R.S. Salas, B. Tombal, H. Van Der Poel, J. Walz, G. De Meerleer, H. Van Poppel, M. Spahn, S. Joniau
Published 2020-07-01

Stratification of high-risk prostate cancer with positive lymph nodes into prognostic groups to predict cancer related death: A European multi-institutional study

by D. Milonas, T. Muilwijk, Z. Venclovas, G. Devos, A. Briganti, P. Gontero, J. Karnes, P. Chlosta, F. Chun, W. Everaerts, C. Gratzke, M. Albersen, M. Graefen, U. Kneitz, G. Marchioro, R.S. Salas, B. Tombal, H. Van Der Poel, J. Walz, G. De Meerleer, H. Van Poppel, M. Spahn, S. Joniau
Published 2020-07-01

Assessing the impact of salvage radiation therapy field after radical prostatectomy: a long-term analysis from a large multi-institutional series

by D. Robesti, N. Fossati, R.J. Karnes, S.A. Boorjan, G. Motterle, A. Bossi, T. Kumar, N. Di Muzio, C. Cozzarini, B.Noris Chiorda, E. Mazzone, G. Giorgio, B. Francesco, S. Simone, D. Bartkowiak, G. Goldner, S. Shariat, G. Devos, S. Joniau, C. Berghen, G. De Meerleer, H. Van Poppel, F. Montorsi, T. Wiegel, A. Briganti
Published 2020-10-01

Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. The importance of patient st...

by C.A. Bravi, N. Fossati, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-07-01

Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. The importance of an extensive, multi-modal ap...

by C.A. Bravi, N. Fossati, G. Motterle, R.J. Karnes, D. Pfister, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-07-01

Assessing the impact of salvage radiation therapy field after radical prostatectomy: A long-term analysis from a large multi-institutional series

by N. Fossati, R.J. Karnes, S.A. Boorjian, G. Motterle, A. Bossi, T. Kumar, N. Di Muzio, C. Cozzarini, B. Noris Chiorda, E. Mazzone, G. Gandaglia, F. Barletta, S. Scuderi, D. Robesti, D. Bartkowiak, S. Shariat, G. Goldner, G. Devos, S. Joniau, C. Berghen, G. De Meerleer, H. Van Poppel, F. Montorsi, T. Wiegel, A. Briganti
Published 2020-07-01

Performance characteristics of PET/CT scan in men treated with salvage lymph node dissection for recurrent prostate cancer: a per patient analysis with pathological confirmation ac...

by E. Zito, N. Fossati, G. Gandaglia, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-10-01

Cure without toxicity: development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

by N. Fossati, R.J. Karnes, S.A. Boorjan, G. Motterle, A. Bossi, T. Kumar, N. Di Muzio, C. Cozzarini, B.Noris Chiorda, E. Mazzone, C.A. Bravi, A. Stabile, G. Gandaglia, V. Cucchiara, D. Bartkowiak, S. Shariat, G. Goldner, G. Devos, S. Joniau, C. Berghen, G. De Meerleer, H. Van Poppel, F. Montorsi, T. Wiegel, A. Briganti
Published 2020-10-01

Cure without toxicity: Development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

by N. Fossati, R.J. Karnes, S.A. Boorjian, G. Motterle, A. Bossi, T. Kumar, N. Di Muzio, C. Cozzarini, B. Noris Chiorda, E. Mazzone, G. Gandaglia, V. Cucchiara, A. Stabile, C.A. Bravi, D. Bartkowiak, S. Shariat, G. Goldner, G. Devos, S. Joniau, C. Berghen, G. De Meerleer, H. Van Poppel, F. Montorsi, T. Wiegel, A. Briganti
Published 2020-07-01